• Appistry to Build Out, Support NIH Rare Disease Exome Pipeline

    Jan 22, 2014, 10:00 AM by Michael Croft
    Bio-IT World | The NIH’s Undiagnosed Diseases Program has turned their diploid aligner tool over to Appistry to make the pipeline “production-ready.” Appistry will host the tool in their cloud, and make the pipeline available to other users with commercial-grade support.
    Full story
  • JP Morgan and the Innovation Landscape

    Jan 20, 2014, 08:00 AM by Michael Croft
    Xconomy | Luke Timmerman sees a power shift in biotech and sums up last week's JP Morgan Healthcare Conference in one line: "It's the healthiest environment for innovation that I've seen in years."
    Full story
  • Acquired by IBM, Aspera Pushes On To the Science DMZ

    Jan 17, 2014, 14:00 PM by Michael Croft
    Bio-IT World | At Aspera, it’s business as usual, Michelle Munson told Bio-IT World this morning, after the announcement that the software company’s acquisition by IBM closed. Aspera’s software development is focused on continuing to increase raw performance; improving ease of use; integration; and developing its software developer kit and APIs.
    Full story
  • Catching Rare Disorders in the First Months of Life

    Jan 16, 2014, 09:15 AM by Michael Croft
    Bloomberg | A U.S. government-funded program is enabling hundreds of infants' genomes to be sequenced in medical centers around the country.
    Full story
  • FDA, 23andMe, and the Democratization of Healthcare

    Jan 15, 2014, 14:00 PM by Michael Croft
    Nature | Robert Green and Nita Farahany take on the FDA's treatment of 23andMe in a Nature comment today. "[R]egulatory constraints might stifle consumer genomics..." the two warned.
    Full story
  • Ingenuity to be Rebranded QIAGEN

    Jan 15, 2014, 12:00 PM by Michael Croft
    Bio-IT World News Brief | Since QIAGEN acquired Ingenuity Systems, Ingenuity has since been trading under the name QIAGEN Redwood City, but QIAGEN has announced that the company will now be branded as such as well.
    Full story
  • What You Need to Know About Illumina's New Sequencers

    Jan 15, 2014, 11:00 AM by Michael Croft
    Bio-IT World | Yesterday, Illumina announced the launch of the HiSeq X "thousand dollar genome" sequencer, and the world's first benchtop high-throughput sequencer, the NextSeq 500. Bio-IT World is here to catch you up on the details and examine the hype.
    Full story
  • Merck's Plans for Chemists, the FDA, and Upcoming Deals

    Jan 15, 2014, 08:00 AM by Michael Croft
    Forbes | Matthew Herper gets Merck on the phone to discuss strategy, the FDA, and organizational changes.
    Full story
  • Illumina Announces the Thousand Dollar Genome

    Jan 14, 2014, 11:25 AM by Michael Croft
    Bio-IT World News Brief | According to Illumina CEO Jay Flatley, the thousand dollar genome is finally here, with the new HiSeq X system already in production and ready to ship this March. The sequencer will be capable of delivering five whole human genomes a day at a cost of just under $1000 apiece.
    Full story
  • Regeneron Partners with Clinical Network on Large Genetic Study

    Jan 14, 2014, 08:30 AM by Michael Croft
    Bio-IT World News Brief | By partnering with Geisinger Health Systems in Pennsylvania, pharmaceutical developer Regeneron will get access to detailed electronic health records on the 100,000 volunteers it plans to sequence over the next five years.
    Full story
  • Wins and Deals at JP Morgan

    Jan 13, 2014, 10:00 AM by Michael Croft
    Xconomy | Luke Timmerman has a good roundup of the buzz and trends at the JP Morgan Healthcare Conference: deals, takeovers, and new target areas in biotech.
    Full story
  • 100,000 Articles - And the Data Scientists Who Mine Them

    Jan 13, 2014, 08:40 AM by Michael Croft
    Bio-IT World | In the wake of another record-setting year at PLOS, Bio-IT World looks behind the curtain at the metadata that helps us search through the world’s largest open access collection of scientific research.
    Full story
  • John Reynders on Building a Cloud-Based Biotech

    Jan 10, 2014, 08:00 AM by Michael Croft
    Bio-IT World | John Reynders has left big pharma to take charge of informatics at Moderna. His goal there is heady: creating a fully cloud-based biotech.
    Full story
  • IBM's Watson: Big Expectations

    Jan 10, 2014, 08:00 AM by Michael Croft
    ReadWrite | IBM hoped that Watson's its Jeopardy-winning supercomputer would be netting the company $1 billion by 2018. Yet over the last three years, the machine only brought in $100 million total.
    Full story
  • Insight Genetics Receives NCI Grant for Lung Cancer Test

    Jan 9, 2014, 15:00 PM by Michael Croft
    Bio-IT World News Brief | Insight Genetics has received a new $1.5 million Phase II Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI), their sixth contract from NCI for companion diagnostics development.
    Full story
  • Powerful Algorithm Promises 'Near-Linear' Scale

    Jan 9, 2014, 09:00 AM by Michael Croft
    Computerworld | MIT researchers have developed a new algorithm that scales in a "near-linear" fashion and could help computers tackle larger, tougher problems much more efficiently.
    Full story
  • Wiley Launches Web Portal to Connect Researchers

    Jan 8, 2014, 11:00 AM by Michael Croft
    Bio-IT World News Brief | Academic publisher John Wiley & Sons today announced a partnership with Boston-area startup Knode to launch a cloud-based portal where users can search for experts in all fields of biomedical research.
    Full story
  • Vivid, Organism-Wide Maps of X-Inactivation

    Jan 8, 2014, 10:55 AM by Michael Croft
    Bio-IT World News Brief | A Johns Hopkins team bred female mice to carry genes for two different fluorescent proteins, one on each X chromosome, resulting in entrancing color images that show patterns of X-inactivation across the body.
    Full story
  • NCI to Fund Cancer Clouds for Cancer Genome Atlas

    Jan 7, 2014, 16:00 PM by Michael Croft
    GCN | The NCI plans to host the Cancer Genome Atlas in the cloud--all 2.5 petabytes of it. NCI plans to award three contracts to build "cancer clouds" for the project.
    Full story
  • Update on JAX's Genomic Medicine Initiative

    Jan 7, 2014, 10:00 AM by Michael Croft
    Hartford Business | By the end of the year, the Jackson Laboratory's new facility will be completed and Charles Lee will lead the Jackson Laboratory for Genomic Medicine.
    Full story